======= RNASEH2B ======= == Gene Information == * **Official Symbol**: RNASEH2B * **Official Name**: ribonuclease H2 subunit B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79621|79621]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5TBB1|Q5TBB1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RNASEH2B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RNASEH2B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610326|Open OMIM]] == Function Summary == * **Entrez Summary**: RNase H2 is composed of a single catalytic subunit (A) and two non-catalytic subunits (B and C) and specifically degrades the RNA of RNA:DNA hybrids. The protein encoded by this gene is the non-catalytic B subunit of RNase H2, which is thought to play a role in DNA replication. Multiple transcript variants encoding different isoforms have been found for this gene. Defects in this gene are a cause of Aicardi-Goutieres syndrome type 2 (AGS2). [provided by RefSeq, Nov 2008]. * **UniProt Summary**: Non catalytic subunit of RNase H2, an endonuclease that specifically degrades the RNA of RNA:DNA hybrids. Participates in DNA replication, possibly by mediating the removal of lagging- strand Okazaki fragment RNA primers during DNA replication. Mediates the excision of single ribonucleotides from DNA:RNA duplexes. {ECO:0000269|PubMed:16845400, ECO:0000269|PubMed:21177858}. |RNase H2-Ydr279| |ribonuclease H2 complex| |regulation of DNA damage checkpoint| |RNA-DNA hybrid ribonuclease activity| |regulation of cell cycle checkpoint| |positive regulation of fibroblast proliferation| |regulation of fibroblast proliferation| |RNA phosphodiester bond hydrolysis, endonucleolytic| |RNA phosphodiester bond hydrolysis| |regulation of G2/M transition of mitotic cell cycle| |regulation of cell cycle G2/M phase transition| |regulation of response to DNA damage stimulus| |RNA catabolic process| |nucleic acid phosphodiester bond hydrolysis| |ribonucleotide metabolic process| |ribose phosphate metabolic process| |nucleobase-containing compound catabolic process| |in utero embryonic development| |regulation of mitotic cell cycle phase transition| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |aromatic compound catabolic process| |nucleotide metabolic process| |regulation of cell cycle phase transition| |nucleoside phosphate metabolic process| |organic cyclic compound catabolic process| |nucleobase-containing small molecule metabolic process| |regulation of mitotic cell cycle| |chordate embryonic development| |embryo development ending in birth or egg hatching| |regulation of cellular response to stress| |regulation of cell cycle process| |organophosphate metabolic process| |cellular macromolecule catabolic process| |positive regulation of cell population proliferation| |embryo development| |carbohydrate derivative metabolic process| |macromolecule catabolic process| |regulation of cell cycle| |regulation of response to stress| |regulation of cell population proliferation| |RNA metabolic process| |negative regulation of gene expression| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp147|Resveratrol 16μM R03 exp147]]|-3.08| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|-2.68| |[[:results:exp464|Calcipotriol 5μM R08 exp464]]|-2.37| |[[:results:exp512|Olaparib 4μM R08 exp512]]|-2.33| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|-2.02| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|-1.99| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-1.91| |[[:results:exp278|CVT-10216 0.1μM R06 exp278]]|-1.75| |[[:results:exp18|Doxycycline 10μM R00 exp18]]|-1.73| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-1.7| |[[:results:exp521|Salinomycin 3.5μM R08 exp521]]|1.72| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|1.87| ^Gene^Correlation^ |[[:human genes:r:rnaseh2a|RNASEH2A]]|0.52| |[[:human genes:r:rabggtb|RABGGTB]]|0.502| |[[:human genes:i:itpa|ITPA]]|0.484| |[[:human genes:s:spr|SPR]]|0.464| |[[:human genes:r:rpp21|RPP21]]|0.457| |[[:human genes:p:ppp4c|PPP4C]]|0.431| |[[:human genes:e:elp2|ELP2]]|0.425| |[[:human genes:m:mcm9|MCM9]]|0.417| |[[:human genes:k:kpna4|KPNA4]]|0.416| |[[:human genes:e:exoc4|EXOC4]]|0.41| |[[:human genes:t:tsen54|TSEN54]]|0.407| |[[:human genes:f:ftsj1|FTSJ1]]|0.406| |[[:human genes:m:mcm8|MCM8]]|0.404| |[[:human genes:r:rnaseh2c|RNASEH2C]]|0.402| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3187 * **Expression level (log2 read counts)**: 6.77 {{:chemogenomics:nalm6 dist.png?nolink |}}